Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins' Clinical Enterprise, Ginkgo Bioworks Partner to Support COVID-19 Testing Program

NEW YORK — Eurofins Scientific subsidiary Clinical Enterprise said on Monday that it has partnered with Ginkgo Bioworks to support a US government program providing no-cost COVID-19 PCR testing to public and private elementary and high schools.

The US Department of Health and Human Services' Operation Expanded Testing Program is designed to provide federally funded COVID-19 testing to children in kindergarten through grade 12, historically Black colleges and universities, and other select community organizations.

To date, Framingham, Massachusetts-based Clinical Enterprise has enrolled schools and organizations in 26 states in the Northeast and Southern US, as well as Washington, D.C., Puerto Rico, and the US Virgin Islands under the program.

Ginkgo, meantime, has been providing COVID-19 testing to over 220,000 individuals weekly through its Concentric public health and biosecurity initiative since last year. In October, Boston-based Ginkgo began working with Quest Diagnostics to provide COVID-19 testing to K-12 schools in Texas.

The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.